Picoplatin  is an  intravenous   platinum -based  chemotherapy  drug that has been designed to overcome the problems normally associated with resistance in chemotherapy regimes using platinum compounds. It was developed by a  Californian  company, Poniard Pharmaceuticals, as a treatment for aggressive small cell lung cancer.